Author

Peter L Lakatos

INCIDENCE, PREDICTIVE FACTORS AND OUTCOMES OF NON-VARICEAL UPPER GASTROINTESTINAL BLEEDING: A PROSPECTIVE MULTICENTER POPULATION-BASED STUDY FROM HUNGARY
INCIDENCE, PREDICTIVE FACTORS AND OUTCOMES OF NON-VARICEAL UPPER GASTROINTESTINAL BLEEDING: A PROSPECTIVE MULTICENTER POPULATION-BASED STUDY FROM HUNGARY

Peter L Lakatos  et al.

INCIDENCE, PREDICTIVE FACTORS AND OUTCOMES OF VARICEAL UPPER GASTROINTESTINAL BLEEDING - A PROSPECTIVE MULTICENTER POPULATION-BASED STUDY FROM HUNGARY
INCIDENCE, PREDICTIVE FACTORS AND OUTCOMES OF VARICEAL UPPER GASTROINTESTINAL BLEEDING - A PROSPECTIVE MULTICENTER POPULATION-BASED STUDY FROM HUNGARY

Peter L Lakatos  et al.

NON-MEDICAL, MANDATORY SWITCH AMONG ADALIMUMAB BIOSIMILARS AND FROM THE ORIGINATOR ADALIMUMAB TO BIOSIMILARS IN INFLAMMATORY BOWEL DISEASE PATIENTS – A PROSPECTIVE, MULTICENTRE STUDY ON EFFICACY, DRUG SUSTAINABILITY AND SAFETY
NON-MEDICAL, MANDATORY SWITCH AMONG ADALIMUMAB BIOSIMILARS AND FROM THE ORIGINATOR ADALIMUMAB TO BIOSIMILARS IN INFLAMMATORY BOWEL DISEASE PATIENTS – A PROSPECTIVE, MULTICENTRE STUDY ON EFFICACY, DRUG SUSTAINABILITY AND SAFETY

Peter L Lakatos  et al.

The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease
The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease

Peter L Lakatos  et al.

ACCURACY OF PANMAYO ENDOSCOPIC SCORE IN PREDICTING LONG-TERM DISEASE OUTCOMES IN ULCERATIVE COLITIS– A PROMISING SCORING SYSTEM
ACCURACY OF PANMAYO ENDOSCOPIC SCORE IN PREDICTING LONG-TERM DISEASE OUTCOMES IN ULCERATIVE COLITIS– A PROMISING SCORING SYSTEM

Peter L Lakatos  et al.

REAL-LIFE EFFECTIVENESS OF TOFACITINIB IN TWO INDICATIONS IN ULCERATIVE COLITIS: A RETROSPECTIVE WORLDWIDE, MULTICENTER, COLLABORATIVE STUDY
REAL-LIFE EFFECTIVENESS OF TOFACITINIB IN TWO INDICATIONS IN ULCERATIVE COLITIS: A RETROSPECTIVE WORLDWIDE, MULTICENTER, COLLABORATIVE STUDY

Peter L Lakatos  et al.

CLINICAL EFFICACY, DRUG SUSTAINABILITY AND RESULTS FROM THERAPEUTIC DRUG MONITORING IN CROHN'S DISEASE PATIENTS TREATED WITH USTEKINUMAB - 1-YEAR FOLLOW-UP OF A PROSPECTIVE, NATIONWIDE, MULTICENTER COHORT FROM HUNGARY
CLINICAL EFFICACY, DRUG SUSTAINABILITY AND RESULTS FROM THERAPEUTIC DRUG MONITORING IN CROHN'S DISEASE PATIENTS TREATED WITH USTEKINUMAB - 1-YEAR FOLLOW-UP OF A PROSPECTIVE, NATIONWIDE, MULTICENTER COHORT FROM HUNGARY

Peter L Lakatos  et al.

Item 21 - 27 / 27
1
2